Of note, the CD8α+ CD103+ cDC1 lineage of cDCs is superior in antigen cross-presentation, a process of presenting exogenous antigens on major histocompatibility complex (MHC) class I to activate CD8+ T cells and are thus particularly important for producing CD8+ T cells that can kill tumor cells.40 This evidence concerns the gene ITGAE and neoplasm.